# FDA recall D-330-2014

> **Novartis Pharmaceuticals Corp.** · Class II · drug recall initiated 2013-08-08.

## Product

Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) 10/320/25 mg, Rx only, 7 tablets per bottle, Physician Sample - Not For Sale. Manufactured by: Novartis Pharma Stein AG Stein, Switzerland.  Distributed by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC # 0078-9563-89

## Reason for recall

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-330-2014
- **Recalling firm:** Novartis Pharmaceuticals Corp.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-08-08
- **Report date:** 2013-12-18
- **Termination date:** 2015-12-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Suffern, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-330-2014

## Citation

> AI Analytics. FDA recall D-330-2014. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-330-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*